Solvay PerSalze GmbH – Trademark Portfolio
Entity Type: 99
Solvay PerSalze GmbH holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include OXYPER.
Hans-Boeckler-Allee 20
30173 Hannover
Showing of trademarks Trademarks
Trademark Classifications
Solvay PerSalze GmbH's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does Solvay PerSalze GmbH have?
Solvay PerSalze GmbH has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered.
What trademark classes does Solvay PerSalze GmbH file in?
Solvay PerSalze GmbH files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Solvay PerSalze GmbH's most well-known trademarks?
Solvay PerSalze GmbH's registered trademark portfolio includes well-known marks such as OXYPER. These are among 1 currently registered trademark in the portfolio.
What is Solvay PerSalze GmbH's trademark registration success rate?
Solvay PerSalze GmbH has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.